Ressearch Unit Meeting | 1st Quarter 2021
Planned Research Unit meeting taking place on January 28th and February 1st, 2020. We are looking forward to an exciting review of new data and fruitful discussions of our projects and future perspectives.
Z2 Research Unit Team Meeting (January 14, 2021)
“Doctors take the lead for patients” | Frankfurter Allgemeine Zeitung special edition
DFG funds research group “ProtectMove” for another three years
The research group “ProtectMove – reduced penetrance in hereditary movement disorders: Elucidation of Mechanisms of Endogenous Disease Protection” at the University of Lübeck is funded by the German Research Foundation (DFG) for a further three years. This decision was made by the Joint Committee of the DFG at its meeting during the Annual General Meeting on 1 July 2020. The spokesperson of the Research Unit, which has been in existence since 2016, is Prof. Dr. Christine Klein, Head of the University’s Institute of Neurogenetics.
On August 1st, 2019, the Deputy CEO of The Michael J. Fox Foundation, Sohini Chowdhury, visited the Institute of Neurogenetics
Anne Weißbach awarded with the David Marsden Award 2019
Dr. Joanne Trinh was invited to the Humboldt Annual Meeting where Chancellor Angela Merkel gave a speech to fellow Humboldtians and a celebration of Alexander Von Humboldt’s 250th birthday at the schloss Bellevue where President Steinmeier lives.
Victor Krajka received a short-term fellowship for his research stay with Dr. Carsten Janke at the Institut Curie in Orsay, France.
Multimodal field study in the Philippines
Field study in the Philippines investigating affected and unaffected carriers of the X-linked dystonia-parkinsonism (XDP) mutation to study penetrance and expressivity of XDP as part of a CCXDP Project and DFG FOR2488.
Talk by Prof. Hyder (Buz) Jinnah, Emory University: “Genotype-Phenotype Correlations in Neurological Disease”.
Retreat of FOR2488
The retreat of research group FOR2488 took place in Bolzano, Italy between April 8th-9th, 2019.
Reduced Penetrance Conference in Lübeck
During the two-day conference (10-11 December) nearly 120 participants came together to share and discuss data and research ideas and to set up new collaborative efforts related to reduced penetrance.
X-linked dystonia-parkinsonism workshop at the Institute of Neurogenetics
The Institute of Neurogenetics and the Movement Disorder Society of the Philippines (MDSP) recently (September 19-21, 2018) organized an X-linked dystonia-parkinsonism workshop in Luebeck.
Topics covered in the workshop included clinical assessment, therapeutic strategies, and functional and molecular neurogenetics. The MDSP also hosted an XDP awareness drive for the Filipino communities in Luebeck and Hamburg.
The Michael J. Fox Foundation awarded an Edward J. Safra Fellowship to the Institute of Neurogenetics. Anne Weissbach, MD is the recipient of this prestigious career development award.
To download the article, click here.
Charles Jourdan Reyes has been awarded a Ph.D. scholarship (Program 2) by the Catholic Academic Exchange Service (KAAD)
The scholarship is given to advanced international students from developing countries to help them reintegrate to their home countries after their graduate studies in Germany. Charles is currently doing research on genetic modifiers of disease penetrance and expressivity in X-linked dystonia-parkinsonism under the supervision of PD Dr. Ana Westenberger.
Congratulations to Kobi Wasner for the “SfN 2018 Trainee Professional Development Award (TPDA)”
PhD candidate Kobi Wasner from the Molecular and Functional Neurobiology Group at the Luxembourg Centre for Systems Biomedicine, has received the “2018 Trainee Professional Development Award (TPDA)” from the Society for Neuroscience for his project entitled: “Investigating a novel role for parkin in mitochondrial DNA maintenance in induced pluripotent stem cell-derived neurons from Parkinson’s disease patients.”
New group on’integrative omics approaches
A junior research group under the Translational Neurogenetics Section has been formed to spearhead genetic and genomic approaches including genome sequencing, deep mito-sequencing, RNA sequencing and epigenetics to identify highly penetrant mutations, risk factors and disease modifying genetic variants in Parkinson’s disease. One focus of this research group will be on genetic modifiers of reduced penetrance, which will strengthen the Research Unit.
The Institute of Neurogenetics is happy to announce the new website launch for the ‘Reduced Penetrance Conference’ 2018.
For more information please visit reducedpenetranceconference.com.
2018 Interim Meeting of the Protect Move Research Unit.
Jannik Prasuhn has been awarded 200.000US$ of the Parkinson’s Foundation Clinical Research Award.
Melissa Vos meeting Nobel Laureate Yoshinori Ohsumi at the Lindau Laureate Meeting.
Kobi Wasner has joined the Institute of Neurogenetics as a visiting scientist.
ProtectMove 2017 Progress Report
First Interim Meeting of the Protect Move Research Unit coming up
December 11 – 12, 2017
Institute of Neurogenetics
To download the agenda, please click here.
The German Academy for Rare Neurological Diseases (Deutsche Akademie für Seltene Neurologische Erkrankungen; DASNE) celebrates its foundation. The event takes place at the Wartburg castle in Eisenach, Germany from November 29th until December 1st. Being the first institution in the area of rare diseases, the DASNE sees itself as a network for bundling expertise with the goal of better patient care.
For more information, please visit dasne.de
Christine Klein was awarded a new research grant from “The Michael J. Fox Foundation for Parkinson’s Research (MJFF)” for the project entitled “Identifying global cohorts with monogenic Parkinson’s disease.”
Christine Klein awarded the Movement Disorder Society’s Distinguished Service Award in Vancouver, Canada on June 4th, 2017
Philip Seibler appointed W2 Professor for Applied Stem Cell Research
Dr. Joanne Trinh has joined the Institute of Neurogenetics as a postdoctoral research fellow.
14.02.2017 – Dr. Joanne Trinh has joined the Institute of Neurogenetics as a postdoctoral research fellow. She completed her PhD studies in genetic modifiers of disease onset in LRRK2 parkinsonism at the University of British Columbia with Prof. Dr. Matthew Farrer (https://www.ncbi.nlm.nih.gov/pubmed/27692902). Her passion for identifying factors that influence onset age of Parkinson disease has led her to join the ‘Reduced Penetrance in Hereditary Movement Disorders – ProtectMove’ DFG Research Unit. She aspires to strengthen the research unit with her expertise in genetics and genomics of penetrance modifiers. We are enthusiastic to have her on the team!
December 19th, 2016
Institute of Neurogenetics